Shenandoah Therapeutics Inc.
South San Francisco, US · Founded 2022 · Delaware corporation · 1 known investors
Find your way into Shenandoah Therapeutics Inc.
Sign up to see every warm intro you have to Shenandoah Therapeutics Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Shenandoah Therapeutics Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
GY

WY
Wendy YoungBoard director
JE
Jim EdwardsBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.5M disclosed across 1 round · 2025
▶$21.5MraisedMay 2025 · 12 investors · Other TechnologyRule 506(b)
▶$21.5MraisedMay 2025 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark StepkaExecutive Officer
- Gary YeungDirector
- Isabella GraefExecutive Officer, Director
- Wendy YoungDirector
- Nathanael GrayDirector
- Jim EdwardsDirector
- Offering amount
- $21.5M
- Amount sold
- $21.5M
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Shenandoah Therapeutics Inc.'s investors?
- Shenandoah Therapeutics Inc.'s investors include YK Bioventures.
- How much funding has Shenandoah Therapeutics Inc. raised?
- Shenandoah Therapeutics Inc. has disclosed $21.5M raised across 1 round.
- Where is Shenandoah Therapeutics Inc. headquartered?
- Shenandoah Therapeutics Inc. is headquartered in South San Francisco, US.